Discovery of 5-Nitro- N -(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Huating Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejian…. Hauptthemen laut MEDLINE: Androgen Receptor Antagonists, Receptors, Androgen, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Jinhua Science and Technology Bureau, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
The transformation of clinical androgen receptor (AR) antagonists into agonists driven by AR mutations poses a significant challenge in treating prostate cancer (PCa). Novel anti-AR therapeutics combating mutation-induced resistance are required. Herein, by combining structure-based virtual screening and biological evaluation, a high-affinity agonist E10 was first discovered. Then guided by the representative conformation of State 1 at the free energy landscape, the structural optimization of E10 was performed, and pure AR antagonists EL15 (IC50 = 0.94 μM) and EF2 (IC50 = 0.30 μM) were successfully identified. Both can antagonize wild-type and variant drug-resistant ARs. Therein, EF2 demonstrated potent inhibition of the AR pathway and effectively suppressed tumor growth in a C4-2B xenograft mouse model following oral administration. Further molecular dynamics simulation and mutagenesis studies revealed atomic insights into the mode of action of EF2 which may serve as a novel lead compound for developing therapeutics against AR-driven PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China.
- Insitute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, Anhui, China.
- Jinhua Institute of Zhejiang University, Jinhua 321000, Zhejiang, China.
- Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang, China.
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, Jiangsu, China.
ORCID-Profile: Haiyang Zhong, Rong Sheng, Peichen Pan, Tingjun Hou, Dan Li
Förderung
- Natural Science Foundation of Jiangsu Province
- Jinhua Science and Technology Bureau
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Wang, H., Wang, X., Zhong, H., Cai, L., Fu, W., Chai, X., Liao, J., Sheng, R., Shan, L., Xu, X., Xu, L., Pan, P., Hou, T., & Li, D. (2024). Discovery of 5-Nitro- N -(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01970
Vancouver
Wang H, Wang X, Zhong H, Cai L, Fu W, Chai X, et al. Discovery of 5-Nitro- N -(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01970
BibTeX
@article{Wang2024,
author = {Wang, Huating and Wang, Xuwen and Zhong, Haiyang and Cai, Lvtao and Fu, Weitao and Chai, Xin and Liao, Jianing and Sheng, Rong and Shan, Luhu and Xu, Xiaohong and Xu, Lei and Pan, Peichen and Hou, Tingjun and Li, Dan},
title = {Discovery of 5-Nitro- N -(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01970}
}
EUVIMED